COc1c(F)c(F)c(C(=O)Nc2ccc(N3CCN(C(C)=O)CC3)c(Cl)c2)c(F)c1F
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?